Skip to main navigation Skip to search Skip to main content

Clinical outcomes of patients referred for left atrial appendage exclusion who did and did not undergo the procedure

  • Trisha Gupte
  • , Mohammed Al-Sadawi
  • , Tiffany Luke
  • , Eryn K. Smith
  • , Nimita Mehta
  • , Jackson J. Liang
  • , Aman Chugh
  • , Fred Morady
  • , Matthew A. Romano
  • , Hakan Oral
  • , Michael Ghannam

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Left atrial appendage exclusion (LAAE) is an effective alternative to long-term anticoagulation in patients with atrial fibrillation. Not all patients considered for LAAE undergo the procedure because of ineligibility, anatomic or medical constraints, and preference of the patient. Objective: The objective of this study was to report on the management strategies and long-term clinical outcomes of patients referred to a dedicated multidisciplinary LAAE clinic, including all who subsequently did and did not undergo LAAE. Methods: This was a retrospective analysis of prospectively acquired data from all patients referred to the comprehensive multidisciplinary LAAE clinic at the University of Michigan between 2016 and 2022. A consecutive 301 patients (age, 75 ± 8 years; 106 women) with atrial fibrillation were evaluated. LAAE was performed in 168 patients (56%) with use of the Watchman device in 146 (49%) and surgically in 22 (7%). LAAE was not performed in 133 patients (44%, no-LAAE group) because of ineligibility in 62 (21%), anatomic constraints in 23 (7%), and preference of the patient in 48 (36%). The CHA2DS2-VASc score (4.7 ± 1.5 vs 4.1 ± 1.6; P = .002) and HAS-BLED score (3.4 ± 1.0 vs 2.8 ± 1.1; P < .001) were higher in the LAAE groups. Results: Anticoagulant therapy was discontinued in 137 of 146 (94%) and 61 of 133 (61%) in the Watchman and no-LAAE groups, respectively (P < .001). During a median follow-up of 2.2 years (interquartile range, 1.2–4.0 years), in the LAAE (n = 168) and no-LAAE (n = 133) groups, respectively, 39 (23%) vs 29 (22%) deaths, 13 (8%) vs 5 (4%) thromboembolic events, and 24 (14%) vs 23 (17%) bleeding complications occurred. Continued long-term anticoagulation was not a predictor of clinical outcomes. Conclusion: After a comprehensive evaluation in a multidisciplinary clinic, ∼50% of the patients referred for LAAE did not proceed with LAAE and resumed anticoagulation.

Original languageEnglish (US)
Pages (from-to)1016-1023
Number of pages8
JournalHeart Rhythm
Volume21
Issue number7
DOIs
StatePublished - Jul 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 Heart Rhythm Society

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticoagulation
  • AtriClip
  • Atrial fibrillation
  • Left atrial appendage exclusion
  • Watchman

Fingerprint

Dive into the research topics of 'Clinical outcomes of patients referred for left atrial appendage exclusion who did and did not undergo the procedure'. Together they form a unique fingerprint.

Cite this